Posts Tagged ‘Gary Slatko’

FDLI Conference on REMS: Benefits and Risks Meet Liabilities and Opportunities

Wednesday, February 24th, 2010

- Guest blog by Roger Morris, The LondonBritian Company -

You’ve heard all the analogies:  Is the glass half empty or half full?  Does the dark storm cloud have a silver lining?

I was constantly reminded of this during the Food & Drug Law Institute’s latest conference on REMS held February 16 in Washington, D.C., as the residents and transportation system was trying to dig out of one-two snowstorms.  It was an interesting conference, one that built substantially on the groundwork done at last year’s REMS conference which the FDLI co-hosted with ParagonRx. (more…)

Tags: , , , , , , , , , , ,
Posted in Pharmaceuticals, REMS | No Comments »

Are You Attending the FDLI’s Important REMS Conference in Washington?

Friday, February 5th, 2010

- Guest blog by  Roger Morris, The LondonBritain Company -

Having worked in communications in the pharmaceutical industry for more than 25 years, I continue to be amazed at how even strong competitors remain so open to sharing information and experiences.  Perhaps it’s the academic nature of pharmaceutical research that filters out to everyone else in the business, but the industry is constantly talking within itself - from scientific publications about new compounds to physician disease-state annual meetings to specialty conferences.

(more…)

Tags: , , , , , ,
Posted in Pharmaceuticals, REMS | No Comments »

Thoughts Shared at FDLI Risk Management Conference

Wednesday, January 28th, 2009

FDA and the industry share thoughts at FDLI risk management conference

Earlier this month, while Washington was bustling with Inaugural preparations, there was an excellent meeting in the capital on pharmaceutical risk management, hosted by the Food and Drug Law Institute (FDLI) at the offices of Morgan, Lewis & Bockius LLP.  The impetus of the meeting was to provide a forum for some of the authors of the recently published text, Pharmaceutical Risk Management: Practical Applications (FDLI, 2008) as well as other experts within the industry and within the FDA.  Industry veteran Wayne Pines, who edited the book along with me and my colleague at ParagonRx, Gary Slatko, chaired the conference.

I would like to share with you some of the more-intriguing thoughts to come out of the conference, as well as a few news tidbits – but first let me say that if you would like to obtain a complete transcript of the conference or to buy a copy of PRM: Practical Applications, please contact the FDLI website at www.fdli.org.
(more…)

Tags: , , , , , , , , , , , , , , , ,
Posted in REMS | No Comments »

Gary Slatko

Wednesday, January 28th, 2009

Gary Slatko, MD, is co-founder of ParagonRx and has an unusually broad background in medical practice and the pharmaceutical business. He was a pioneer in the disease management field at Zeneca and GlaxoSmithKline and was also a business executive at DuPont Merck. With this diverse experience over twenty years, Gary is in charge of developing ParagonRx’s products and services. He received his Doctor of Medicine from the University of Miami (Florida) and his MBA from West Chester University.

Gary can be reached at (302)504-0400 x227 or gslatko@paragonrx.com

Tags: ,
Posted in Pharmaceuticals | No Comments »